kabutan

OncoTherapy Science, Jul-Sep (2Q) Net Income Loss Narrows

Fri Nov 7, 2025 5:00 pm JST Earnings

4564 OncoTherapy Science, Inc. 【J-GAAP】

Earnings Report

OncoTherapy Science, Inc. <4564> [TSE Growth] announced its financial results after the market closed on November 7th (17:00). The consolidated net loss for the cumulative second quarter of the fiscal year ending March 2026 (April to September) expanded to a loss of 555 million yen (compared to a loss of 545 million yen in the same period last year).

In the most recent three-month period, from July to September (2Q), the consolidated net loss improved to a deficit of 241 million yen (compared to a loss of 243 million yen in the same period last year). The operating profit/loss margin improved from -192.8% in the same period last year to -74.8%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2023 356 -694 -708 -710 -3.4 ー Nov 10, 2023 J-GAAP
Apr - Sep, 2024 225 -531 -545 -545 -2.2 ー Nov 8, 2024 J-GAAP
Apr - Sep, 2025 431 -475 -493 -555 -1.9 ー Nov 7, 2025 J-GAAP
YoY +91.6% +10.5% +9.5% -1.8% +13.3%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2025 Guidance ー ー ー ー － － May 9, 2025 J-GAAP
Apr - Sep, 2025 Results 431 -475 -493 -555 -1.9 － Nov 7, 2025 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 525 -266 -270 -270 -1.0 0 May 9, 2025 J-GAAP
Oct - Mar, 2025 Guidance ー ー ー ー － 0 May 9, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 610 -1,120 -1,136 -1,288 -6.1 0 May 10, 2024 J-GAAP
Mar, 2025 750 -797 -815 -815 -3.1 0 May 9, 2025 J-GAAP
Mar, 2026 Guidance ー ー ー ー － 0 May 9, 2025 J-GAAP
YoY － － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2024 125 -241 -243 -243 -1.0 -192.8 Nov 8, 2024 J-GAAP
Oct - Dec, 2024 338 -167 -171 -172 -0.7 -49.4 Feb 7, 2025 J-GAAP
Jan - Mar, 2025 187 -99 -99 -98 -0.4 -52.9 May 9, 2025 J-GAAP
Apr - Jun, 2025 201 -303 -313 -314 -1.1 -150.7 Aug 8, 2025 J-GAAP
Jul - Sep, 2025 230 -172 -180 -241 -0.8 -74.8 Nov 7, 2025 J-GAAP
YoY +84.0% +28.6% +25.9% +0.8% +15.5%

Related Articles